| Good News regarding the joint venture: Quick Results! Hope this results in some stock movement!    Len 
 RANCHO CORDOVA, Calif.--(BW HealthWire)--Dec. 14, 1998--An
 intravascular ultrasound-guided stent delivery system jointly developed by
 EndoSonics Corporation (NASDAQ:ESON) and JOMED AB of Helsingborg,
 Sweden, was successfully deployed during the second Cardiovascular Summit in
 Rotterdam, The Netherlands, December 8 - 12.
 
 During a live case transmission, cardiologists at the Thorax Center of Erasmus
 University in Rotterdam used the integrated therapeutic device to perform primary
 stenting on a 73-year-old patient, the first use of the system developed by
 EndoSonics and JOMED under an agreement in principle reached last September.
 
 "Integrating this intravascular imaging technology on a stent delivery system
 provides an efficient and effective tool for the physician to optimize stent
 placement, which we know improves clinical outcome," said Professor Patrick W.
 Serruys, a noted interventional cardiologist and principal organizer of the
 Cardiovascular Summit.
 
 The therapeutic device integrates EndoSonics' ultrasound catheter with a JOMED
 stent and balloon. JOMED and EndoSonics will market the new product through
 JOMED's direct operations and through joint partners in several European
 countries.
 
 "This initial demonstration marks the end of the system's developmental phase,
 which was completed quickly and efficiently in less than three months," noted
 EndoSonics President and Chief Executive Officer Reinhard J. Warnking. "With
 this breakthrough therapeutic device, physicians have the comfort of a premounted
 stent, combined with the ability to immediately assess the results of the procedure
 and complete any necessary refinements before removing the catheter."
 
 Tor Peters, JOMED President and CEO, called the combined therapeutic device's
 introduction "a major advancement in image-guided therapy in Europe," adding
 that the product is expected to be introduced during the first quarter of 1999
 following regulatory (CE mark) approval.
 
 
 |